BCHM 163
Hofstra University
All 4 results
Sort by
-
XL-765
- Package deal • 2 items • 2023
-
- $50.49
- + learn more
XL-765 is a small molecule inhibitor of phosphoinositide 3-kinase (PI3K) and mTOR (mammalian target of rapamycin) signaling pathways. These pathways are often overactive in cancer cells, making them attractive targets for cancer therapy.
-
XL-765 cancer metabolism BCHM 163
- Summary • 3 pages • 2023
-
- $20.49
- + learn more
XL-765 is a small molecule inhibitor of phosphoinositide 3-kinase (PI3K) and mTOR (mammalian target of rapamycin) signaling pathways. These pathways are often overactive in cancer cells, making them attractive targets for cancer therapy.
-
Presentation BCHM 163
- Presentation • 6 pages • 2023
- Available in package deal
-
- $20.49
- + learn more
XL-765 is a small molecule inhibitor of phosphoinositide 3-kinase (PI3K) and mTOR (mammalian target of rapamycin) signaling pathways. These pathways are often overactive in cancer cells, making them attractive targets for cancer therapy.
-
Summary XL-765 BCHM 163
- Summary • 1 pages • 2023
- Available in package deal
-
- $20.49
- + learn more
XL-765 is a small molecule inhibitor of phosphoinositide 3-kinase (PI3K) and mTOR (mammalian target of rapamycin) signaling pathways. These pathways are often overactive in cancer cells, making them attractive targets for cancer therapy.
As you read this, a fellow student has made another $4.70
How did he do that? By selling his study resources on Stuvia. Try it yourself! Discover all about earning on Stuvia